explore -WSS

explore

author：fashion 2025-09-05 09:09:45 - browse：8311

Adobe

The medical device industry is split on whether a proposed new Medicare reimbursement pathway will do anything to soothe their insurance coverage woes.

Device makers have long complained that the unclear, rocky road to payment kills innovative companies. So they were thrilled when the Trump administration proposed a rule that would have guaranteed four years of Medicare coverage of approved devices deemed “breakthroughs” by the Food and Drug Administration. They hoped private payers would follow suit. But in 2021, under a new administration and a push for more device scrutiny, the Centers for Medicare and Medicaid pulled back on the idea, promising a replacement that would streamline coverage for innovative devices while ensuring safe, high-quality care.

The pathway put forth last week, called Transitional Coverage for Emerging Technologies (TCET), is only a notice, not yet a rule that would grant CMS new powers. The program applies solely to devices that have earned a place in the FDA’s breakthrough device program, which was established to identify devices that the agency believed could provide “more effective” treatment or diagnosis of serious conditions than the current standard of care. But because those devices can be brought to market with less certainty in their benefits and risks than other products, experts said, the idea of automatic reimbursement was dicey.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： What nurses really want: sufficient staffing for patient care

explore

WSS

What to know about 'Guardians of the Galaxy Vol. 3' as it hits Disney+

Study: Adult vaccinations pay for themselves in societal benefits

Medicare says breakthrough device reimbursement rule to come by summer

Scientists find bacteria from stomach of ancient iceman

'Cuddling' is just what the doctor ordered for a 200

Telehealth startups turn to complex chronic diseases

Wikipedia

explore

entertainment

Jerome Adams on the need for new antivirals for Covid

Judge in Trump's Jan. 6 case gives attorneys 2 weeks to propose trial date

In Memoriam: Notable people who died in 2023

Use wet bulb globe temperature, not heat index, to protect workers

23andMe had bad news about my health. I wish a person had delivered it

Google says AlphaFold 3 can map a vast universe of biomolecules

Medicare proposal to cover medical devices draws a mixed reaction

Apple Watch's A

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Elevance, private equity launch primary care company

knowledge

Medicare says breakthrough device reimbursement rule to come by summer

H5N1 communication has been strictly for the birds

Flash flooding emergencies prompt evacuations in Kentucky, Tennessee

Readout LOUD podcast: What to know about H5N1 bird flu

First recipient of genetically engineered pig kidney has died

'Cuddling' is just what the doctor ordered for a 200

explore

hotspot

explore

knowledge